These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 885160)
1. Central serotonin-like activity of 6-chloro-2-[1-piperazinyl]-pyrazine (CPP; MK-212). Clineschmidt BV; Mcguffin JC; Pflueger AB Eur J Pharmacol; 1977 Jul; 44(1):65-74. PubMed ID: 885160 [TBL] [Abstract][Full Text] [Related]
2. A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212). Clineschmidt BV; McGuffin JC; Pflueger AB; Totaro JA Br J Pharmacol; 1978 Apr; 62(4):579-89. PubMed ID: 656703 [TBL] [Abstract][Full Text] [Related]
3. Piperazinylpyrazines with central serotoninmimetic activity. Lumma WC; Hartman RD; Saari WS; Engelhardt EL; Hirschmann R; Clineschmidt BV; Torchiana ML; Stone CA J Med Chem; 1978 Jun; 21(6):536-42. PubMed ID: 671450 [TBL] [Abstract][Full Text] [Related]
4. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. Lucki I; Ward HR; Frazer A J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329 [TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological differentiation of the central 5-hydroxytryptamine-like actions of MK-212 (6-chloro-2[1-piperazinyl]-pyrazine),p-methoxyamphetamine and fenfluramine in an in vivo model system. Clineschmidt BV; McGuffin JC Eur J Pharmacol; 1978 Aug; 50(4):369-75. PubMed ID: 151629 [No Abstract] [Full Text] [Related]
8. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141 [TBL] [Abstract][Full Text] [Related]
9. Central serotoninmimetic action of phenylpiperazines. Maj J; Lewandowska A Pol J Pharmacol Pharm; 1980; 32(4):495-504. PubMed ID: 7255267 [TBL] [Abstract][Full Text] [Related]
10. Serotonin-like actions of quipazine and CPP on spinal motoneurones. Neuman RS; White SR Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370 [TBL] [Abstract][Full Text] [Related]
11. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866 [TBL] [Abstract][Full Text] [Related]
12. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Darmani NA; Johnson JC Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052 [TBL] [Abstract][Full Text] [Related]
13. 6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine. Lotti VJ; Clineschmidt BV; Haubrich D; Porter CC Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):103-15. PubMed ID: 153735 [TBL] [Abstract][Full Text] [Related]
14. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro -beta-carbolin-1-one (B-193). Wiczyńska B; Chojnacka-Wójcik E; Rokosz-Pelc A; Mazela H; Przegaliński E Pol J Pharmacol Pharm; 1989; 41(2):169-81. PubMed ID: 2556691 [TBL] [Abstract][Full Text] [Related]
15. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury. Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520 [TBL] [Abstract][Full Text] [Related]
16. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Meller ST; Lewis SJ; Brody MJ; Gebhart GF Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336 [TBL] [Abstract][Full Text] [Related]
17. MK-212: a serotonin-like agonist in the CNS. Clineschidmt BV Gen Pharmacol; 1979; 10(4):287-90. PubMed ID: 488663 [No Abstract] [Full Text] [Related]
18. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade. Calcagno E; Carli M; Baviera M; Invernizzi RW J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357 [TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. Hackler EA; Turner GH; Gresch PJ; Sengupta S; Deutch AY; Avison MJ; Gore JC; Sanders-Bush E J Pharmacol Exp Ther; 2007 Mar; 320(3):1023-9. PubMed ID: 17138863 [TBL] [Abstract][Full Text] [Related]
20. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes. Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]